Home glaxosmithkline
 

Keywords :   


Tag: glaxosmithkline

Why Raleigh-Durham International Airport needs a new GlaxoSmithKline

2015-04-18 19:33:31| Biotech - Topix.net

When American Airlines decided to take a bet on a nonstop flight from Raleigh-Durham International Airport to London decades ago, it was because of one company: Glaxo - now called GlaxoSmithKline . The British drug maker is still a frequent flyer, despite its recent headcount reductions in Research Triangle Park .

Tags: new international airport international airport

 

GlaxoSmithKline to open global R&D center in Rockville

2015-04-02 20:32:57| Biotech - Topix.net

The GlaxoSmithKline company logo is seen on the GlaxoSmithKline Plc headquarters in London, U.K. The pharmaceutical giant announced Thursday it will located its U.S. vaccine research and development in Rockville. Pharmaceutical giant GlaxoSmithKline PLC will open a new global center for vaccine research and development in Rockville, the company announced Thursday .

Tags: center open global glaxosmithkline

 
 

GlaxoSmithKline sees sales fall

2015-02-04 15:18:00| BBC News | Business | UK Edition

Drugs giant GlaxoSmithKline (GSK) reports a drop in fourth-quarter sales as demand for its asthma drug Advair remains weak.

Tags: sales fall sees glaxosmithkline

 

Exclusive: More unit IPOs an option for evolving GlaxoSmithKline

2015-01-16 15:18:17| Biotech - Topix.net

GlaxoSmithKline could consider more partial public share offerings for component units as it evolves in the coming years, potentially pointing to a break-up of the group if this offers value to shareholders. Chief Executive Andrew Witty told Reuters the group's large consumer health business would be more viable as a standalone operation following the conclusion of a $20 billion asset swap with Novartis NOVN.VX, especially if it bought additional assets.

Tags: option unit exclusive ipos

 

This Tiny Biotech Worries Sanofi and Shire, and Vexes GlaxoSmithKline

2014-12-14 16:15:36| Biotech - Topix.net

Doctors may soon have a new therapy to use when treating patients with Fabry Disease, a rare genetic disease that can result in kidney failure. That's because emerging biotech stock Amicus Therapeutics will likely be kicking itself for returning its co-commercialization rights to the drug back to Amicus last year, and for selling its equity stake in Amicus this past October.

Tags: tiny biotech worries shire

 

Sites : [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] next »